Médecine
MENULévothyrox®, Avandia®, Mediator® : la faillite des agences Volume 6, numéro 10, Décembre 2010
Auteur
Endocrinologue, Hôpital Pasteur, 68000 Colmar
- Mots-clés : agence gouvernementale, générique, risque
- DOI : 10.1684/med.2010.0627
- Page(s) : 440-2
- Année de parution : 2010
For those interested in both pharmacovigilance and endocrinology, the year 2010 has been “auspicious”: Levothyrox®, Avandia®, Mediator®... One can conclude from weaknesses in the drug policy in France: political bounded generics, drug-winded and opaque decisions disconnected from the benefit/risk balance, lack of information policy on medication and overall reflection on its proper use...